(1) The board is authorized to approve hospital residency programs in the practice of pharmacy. Persons accepted into an approved hospital residency program who are licensed to practice pharmacy in another state are exempt from the licensing requirements of this article 280 so long as their practice is limited to participation in the residency program.
(2) This article 280 does not apply to the sale or delivery of a dialysis solution if all of the following conditions are met:
The sale or delivery is made directly by the manufacturer to a person with chronickidney failure or to the designee of the person;
The sale or delivery is for the purpose of self-administration by the person pursuantto an order by a physician lawfully practicing in this state; and
The solution is sold or delivered in original packages, properly labeled, and unadulterated in accordance with the requirements of the "Colorado Food and Drug Act", part 4 of article 5 of title 25, and the "Federal Food, Drug, and Cosmetic Act", 21 U.S.C. sec. 301 et seq., as amended.
A manufacturer that must obtain a prescription drug or device solely for use in itsresearch, development, or testing procedures and that does not further distribute the drug or device may apply to the board for a waiver of registration pursuant to this subsection (3). The board may grant a waiver if the manufacturer submits to the board the name of the drug or device it requires and an affidavit certifying that the drug or device will only be used for necessary research, development, or testing procedures and will not be further distributed. A waiver granted pursuant to this subsection (3) does not apply to a controlled substance, as defined in section 18-18-102 (5), or in federal law.
An employee of a facility, as defined in section 25-1.5-301, who is administering andmonitoring medications to persons under the care or jurisdiction of the facility pursuant to part 3 of article 1.5 of title 25 need not be licensed by the board to lawfully possess controlled substances under this article 280.
Source: L. 2019: Entire title R&RE with relocations, (HB 19-1172), ch. 136, p. 1455, § 1, effective October 1.
Editor's note: This section is similar to former § 12-42.5-113 as it existed prior to 2019.